Ogiso T, Iwaki M, Konishi Y
J Pharmacobiodyn. 1984 Mar;7(3):186-94. doi: 10.1248/bpb1978.7.186.
The possible effects of digoxin on the elimination and anticoagulant action of warfarin were examined in rats. The pharmacokinetic parameters of warfarin after a single i.v. (1.2 mg/kg) or repeated oral coadministration with anticoagulant (0.6 mg/kg on day 1, thereafter 0.3 mg/kg) and digoxin (50 micrograms/kg) were not significantly different as compared with those in the group treated with warfarin alone. However, prothrombin complex activity (PCA) following coadministration with the diuretic was significantly and relatively rapidly recovered as compared with that in the warfarin group. The amounts of warfarin extracted by liver 2 and 6 h after a single i.v. dosing or 3 and 8 h after repeated oral dosing in the coadministered group were significantly decreased as compared with those in the group received warfarin alone. The renal function (renal plasma flow rate (RPF) and glomerular filtration rate) in the group coadministered with digoxin was significantly higher than that in the group receiving warfarin alone. On the other hand, the fraction of warfarin bound to BSA or rat plasma and the plasma water were little changed in the presence of digoxin. These results suggest that a pharmacological interaction, the decrease in the anticoagulant action, is induced between warfarin and digoxin coadministered.
在大鼠中研究了地高辛对华法林消除及抗凝作用的可能影响。与单独给予华法林的组相比,单次静脉注射(1.2 mg/kg)或与抗凝剂(第1天0.6 mg/kg,此后0.3 mg/kg)及地高辛(50 μg/kg)重复口服联合给药后,华法林的药代动力学参数无显著差异。然而,与华法林组相比,联合使用利尿剂后的凝血酶原复合物活性(PCA)显著且相对较快地恢复。联合给药组单次静脉注射给药后2小时和6小时或重复口服给药后3小时和8小时肝脏中提取的华法林量,与单独接受华法林的组相比显著减少。联合使用地高辛组的肾功能(肾血浆流量(RPF)和肾小球滤过率)显著高于单独接受华法林的组。另一方面,在有地高辛存在的情况下,华法林与牛血清白蛋白或大鼠血浆结合的比例以及血浆水几乎没有变化。这些结果表明,联合使用华法林和地高辛之间会诱导一种药理相互作用,即抗凝作用减弱。